Original Webinar Date: 04/12/2024

Liquid biopsy’s role in biomarker-driven NSCLC Management

Discover how Dr. Wade Iams of Vanderbilt University is utilizing liquid biopsy as a valuable tool for broad biomarker detection and monitoring resistance mechanisms to therapeutic pressure in NSCLC.
Speakers Wade Iams, MD
Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center

Gary I. Grad, MD
Senior Medical Oncologist, Tempus

Ezra Cohen, MD FRCPSC, FASCO
Chief Medical Officer of Oncology, Tempus

Related Content

View more